JP2014533518A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533518A5
JP2014533518A5 JP2014542951A JP2014542951A JP2014533518A5 JP 2014533518 A5 JP2014533518 A5 JP 2014533518A5 JP 2014542951 A JP2014542951 A JP 2014542951A JP 2014542951 A JP2014542951 A JP 2014542951A JP 2014533518 A5 JP2014533518 A5 JP 2014533518A5
Authority
JP
Japan
Prior art keywords
polypeptide
ugt
seq
amino acid
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014542951A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533518A (ja
JP6084983B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/002857 external-priority patent/WO2013076577A1/en
Publication of JP2014533518A publication Critical patent/JP2014533518A/ja
Publication of JP2014533518A5 publication Critical patent/JP2014533518A5/ja
Application granted granted Critical
Publication of JP6084983B2 publication Critical patent/JP6084983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014542951A 2011-11-23 2012-11-19 モグロシド化合物の酵素的合成のための方法および材料 Active JP6084983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161563303P 2011-11-23 2011-11-23
US61/563,303 2011-11-23
PCT/IB2012/002857 WO2013076577A1 (en) 2011-11-23 2012-11-19 Methods and materials for enzymatic synthesis of mogroside compounds

Publications (3)

Publication Number Publication Date
JP2014533518A JP2014533518A (ja) 2014-12-15
JP2014533518A5 true JP2014533518A5 (cg-RX-API-DMAC7.html) 2016-09-29
JP6084983B2 JP6084983B2 (ja) 2017-02-22

Family

ID=47624376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014542951A Active JP6084983B2 (ja) 2011-11-23 2012-11-19 モグロシド化合物の酵素的合成のための方法および材料

Country Status (14)

Country Link
US (2) US9920349B2 (cg-RX-API-DMAC7.html)
EP (1) EP2783009B1 (cg-RX-API-DMAC7.html)
JP (1) JP6084983B2 (cg-RX-API-DMAC7.html)
KR (1) KR101791597B1 (cg-RX-API-DMAC7.html)
CN (1) CN103958693B (cg-RX-API-DMAC7.html)
AU (2) AU2012342114B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014012543A2 (cg-RX-API-DMAC7.html)
CA (1) CA2853677C (cg-RX-API-DMAC7.html)
IN (1) IN2014CN03557A (cg-RX-API-DMAC7.html)
MX (1) MX342851B (cg-RX-API-DMAC7.html)
MY (1) MY170686A (cg-RX-API-DMAC7.html)
RU (1) RU2633644C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201401927PA (cg-RX-API-DMAC7.html)
WO (1) WO2013076577A1 (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ604915A (en) 2010-06-02 2014-10-31 Evolva Nutrition Inc Recombinant production of steviol glycosides
SG10201606567TA (en) 2011-08-08 2016-10-28 Evolva Sa Recombinant production of steviol glycosides
IN2014CN03557A (cg-RX-API-DMAC7.html) 2011-11-23 2015-10-09 Evolva Sa
TW201402599A (zh) * 2012-05-30 2014-01-16 Suntory Holdings Ltd 甜菊糖苷糖苷轉化酵素及編碼該酵素之基因
WO2014086842A1 (en) * 2012-12-04 2014-06-12 Evolva Sa Methods and materials for biosynthesis of mogroside compounds
CN105189771B (zh) 2013-02-11 2019-11-05 埃沃尔瓦公司 在重组宿主中有效产生甜菊醇糖苷
BR112017002783A2 (pt) 2014-08-11 2017-12-19 Evolva Sa produção de glicosídeos de esteviol em hospedeiros recombinantes
MY191735A (en) 2014-09-09 2022-07-13 Evolva Sa Production of steviol glycosides in recombinant hosts
CA2972739A1 (en) * 2014-09-11 2016-03-17 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Methods of producing mogrosides and compositions comprising same and uses thereof
CA2963300C (en) 2014-10-01 2024-04-30 Evolva Sa Methods and materials for biosynthesis of mogroside compounds
JP6698028B2 (ja) 2014-10-17 2020-05-27 サントリーホールディングス株式会社 モグロール配糖体化酵素およびそれをコードする遺伝子
JP6850130B2 (ja) 2015-01-20 2021-03-31 サントリーホールディングス株式会社 モグロシドの調製方法
JP2018503388A (ja) 2015-01-30 2018-02-08 エヴォルヴァ エスアー.Evolva Sa. 組み換え宿主におけるステビオールグリコシドの生産
CN115851470B (zh) 2015-03-16 2025-09-02 帝斯曼知识产权资产管理有限公司 Udp-糖基转移酶
AU2016307066A1 (en) 2015-08-07 2018-02-08 Evolva Sa Production of steviol glycosides in recombinant hosts
CN108473528A (zh) 2015-10-29 2018-08-31 赛诺米克斯公司 高强度甜味剂
CN106924274B (zh) * 2015-12-29 2019-01-04 成都普睿法药物研发有限公司 葫芦烷型四环三萜类化合物抗肺纤维化应用
SG11201808856TA (en) 2016-04-13 2018-11-29 Evolva Sa Production of steviol glycosides in recombinant hosts
AU2017267214A1 (en) * 2016-05-16 2018-11-15 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2017198682A1 (en) 2016-05-16 2017-11-23 Evolva Sa Production of steviol glycosides in recombinant hosts
CN109477126B (zh) * 2016-07-19 2023-06-20 三得利控股株式会社 罗汉果醇或罗汉果醇糖苷的生产方法
EP3535406A1 (en) 2016-11-07 2019-09-11 Evolva SA Production of steviol glycosides in recombinant hosts
WO2018204483A2 (en) 2017-05-03 2018-11-08 Senomyx, Inc. Methods for making high intensity sweeteners
MX2019013696A (es) 2017-05-19 2020-01-27 Coca Cola Co Composiciones edulcoradas de siamenósido i y usos de las mismas.
CA3064334A1 (en) 2017-06-02 2018-12-06 Givaudan Sa Compositions
WO2021214008A1 (en) 2020-04-20 2021-10-28 Givaudan Sa Compositions
EP3638804A1 (en) 2017-06-15 2020-04-22 Evolva SA Production of mogroside compounds in recombinant hosts
CN107189976B (zh) * 2017-07-28 2022-03-11 李华政 促进罗汉果ugt72b21基因表达的方法
KR20210089717A (ko) 2018-11-07 2021-07-16 피르메니히 인코포레이티드 고강도 감미료의 제조 방법
WO2020096905A1 (en) 2018-11-07 2020-05-14 Firmenich Incorporated Methods for making high intensity sweeteners
CN113302298B (zh) 2018-11-09 2025-02-25 银杏生物制品公司 罗汉果甙的生物合成
CN110669094B (zh) * 2019-10-14 2021-12-21 上海交通大学 罗汉果新苷及其制备方法
KR102362135B1 (ko) * 2019-10-25 2022-02-14 고려대학교 산학협력단 테르펜 당쇄 부가 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 조성물
BR112022018627A2 (pt) * 2020-03-17 2022-12-20 Coca Cola Co Sistemas e métodos inovadores de produção de mogrosídeo
GB202007984D0 (en) 2020-05-28 2020-07-15 Givaudan Sa Compositions
CN112063647B (zh) * 2020-09-17 2023-05-02 云南农业大学 酿酒酵母重组菌Cuol01的构建方法、酿酒酵母重组菌Cuol02及应用
CN116064712B (zh) * 2022-10-08 2025-05-06 中国药科大学 一种罗汉果醇的生物合成方法
CN121127603A (zh) 2023-04-20 2025-12-12 帝斯曼知识产权资产管理有限公司 用于产生罗汉果苷的菌株和方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399321B1 (en) * 1999-08-18 2002-06-04 National Research Council Of Canada Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT
EP1510573A1 (en) * 2003-09-01 2005-03-02 Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung Method for detoxification of mycotoxins
US20080148432A1 (en) * 2005-12-21 2008-06-19 Mark Scott Abad Transgenic plants with enhanced agronomic traits
EP1871883A1 (en) 2005-03-02 2008-01-02 Metanomics GmbH Process for the production of fine chemicals
US8257948B1 (en) * 2011-02-17 2012-09-04 Purecircle Usa Method of preparing alpha-glucosyl Stevia composition
US8956677B2 (en) 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
RU2455854C2 (ru) 2005-11-23 2012-07-20 Дзе Кока-Кола Компани Композиция интенсивного подсластителя с глюкозамином и подслащенные ею композиции
US7927851B2 (en) 2006-03-21 2011-04-19 Vineland Research And Innovation Centre Compositions having ent-kaurenoic acid 13-hydroxylase activity and methods for producing same
US20100143975A1 (en) * 2006-11-22 2010-06-10 The University Of York Monoterpenoid modifying enzymes
WO2008065370A2 (en) * 2006-12-01 2008-06-05 The University Of York Sesquiterpenoid modifying enzymes
GB0904639D0 (en) * 2009-03-18 2009-04-29 Univ York Assay
NZ604915A (en) 2010-06-02 2014-10-31 Evolva Nutrition Inc Recombinant production of steviol glycosides
IN2014CN03557A (cg-RX-API-DMAC7.html) 2011-11-23 2015-10-09 Evolva Sa
WO2014086842A1 (en) 2012-12-04 2014-06-12 Evolva Sa Methods and materials for biosynthesis of mogroside compounds

Similar Documents

Publication Publication Date Title
JP2014533518A5 (cg-RX-API-DMAC7.html)
Schoeman et al. Coronavirus envelope protein: current knowledge
Duan et al. The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens
JP2023179436A5 (cg-RX-API-DMAC7.html)
Tsai et al. Baculovirus as versatile vectors for protein display and biotechnological applications
JP2018520997A5 (cg-RX-API-DMAC7.html)
JP2012095652A5 (cg-RX-API-DMAC7.html)
JP2012531208A5 (cg-RX-API-DMAC7.html)
Maeda et al. The intracellular association of the nucleocapsid protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9)
EP2385107A8 (en) Lentiviral vector based immunological compounds against malaria
JP2008524261A5 (cg-RX-API-DMAC7.html)
RU2015152086A (ru) Пептиды, подавляющие инфекции респираторных вирусов, их применение и способы получения
Florian et al. Characterization of the anti‐HBV activity of HLP1–23, a human lactoferrin‐derived peptide
Berglund et al. Viral alteration of cellular translational machinery increases defective ribosomal products
Molouki et al. The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain
Li et al. Identification and characterization of a prawn white spot syndrome virus gene that encodes an envelope protein VP31
RU2015148190A (ru) Слитые полипептиды и вакцины
AU2016313660B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
CN104404005A (zh) 禽流感病毒ha基因重组腺病毒的制备方法
Liang et al. The role of F1 ATP synthase beta subunit in WSSV infection in the shrimp, Litopenaeus vannamei
CN114736293B (zh) SARS-CoV-2中和性纳米抗体、自组装铁蛋白融合纳米抗体及制备方法和应用
JP2010279373A5 (cg-RX-API-DMAC7.html)
Zhu et al. Transcription and identification of a novel envelope protein (VP124) gene of shrimp white spot syndrome virus
Jie et al. The C-terminal region of envelope protein VP38 from white spot syndrome virus is indispensable for interaction with VP24
Chen et al. Characterization of a novel envelope protein WSV010 of shrimp white spot syndrome virus and its interaction with a major viral structural protein VP24